Rupture of Breast Implants Does Not Cause Systemic or Local Immune Changes

Area of Science:

• Immunology
• Plastic Surgery
• Biomaterials Science

Background:

• Breast implant rupture is a common complication, with risks ranging from 5.3% to 15.1% over 10 years.
• Concerns persist regarding breast implants and immune system effects, despite limited evidence for autoimmune links.
• Previous research has not conclusively established a connection between implant rupture and autoimmune symptoms.

Purpose of the Study:

• To investigate systemic and local immune responses following breast implant rupture.
• To determine if ruptured breast implants trigger immune system changes.
• To explore potential immune system dysregulation in patients experiencing autoimmune-like symptoms post-rupture.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) to measure systemic antibody levels against breast-related antigens.
• Bulk RNA-sequencing of adjacent breast tissue to identify differentially expressed genes (DEGs).
• Comparison of immune markers between healthy females with ruptured versus intact breast implants.

Main Results:

• No significant differences in systemic antibody levels were observed between intact and ruptured breast implants.
• Subgroup analyses showed no immune variations based on implant material, placement, or texture.
• RNA-sequencing identified only one immune-related gene (MS4A1) downregulated in tissue adjacent to ruptured implants, related to B cell activity.

Conclusions:

• Breast implant rupture is not associated with systemic immune alterations or local gene expression changes in breast tissue.
• The study found no evidence supporting a link between implant rupture and the autoimmune-like symptoms reported by some patients.
• Further research may be needed to understand the complex interplay between breast implants and patient immune responses.